Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion
- 1 September 2009
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 283 (1) , 29-35
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell linesInternational Journal of Cancer, 2009
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrixLife Sciences, 2006
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and InvasionClinical Cancer Research, 2004
- CXCL12–CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasionLaboratory Investigation, 2004
- Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cellsOncogene, 2003
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell linesJournal of Cancer Research and Clinical Oncology, 1993
- Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalaciaCancer, 1983